Research News
View articles by month and year
1–1 of article
-
Efaproxiral Doesn’t Improve Radiation Benefits Against Metastatic Breast Cancer in Brain
New research suggests that the experimental medicine Efaproxyn (chemical name: efaproxiral) doesn't improve the benefits of radiation therapy to the brain to treat breast cancer that has spread there.
1–1 of article
